HUM-MOLGEN events: PHAGE DISPLAY TECHNOLOGIES

HUM-MOLGEN -> Events -> Meetings and Conferences

December 06, 2000

Cambridge Healthtech Institute, Cambridge, Massachusetts
April 9-10, 2001

Phage display has proven to be a powerful enabling technology in genomics and drug development. The directed evolution of proteins can be engineered for specific properties and selectivity. It provides an approach for the engineering of human antibodies, as well as protein ligands, and for such diverse applications as arrays, separations, and drug development. The use of phage display in screening for novel high-affinity ligands and their receptors has been useful in functional genomics and proteomics. Display methods promise to have benefit in the development of therapeutics targeting many different disorders, including cancer, AIDS, and autoimmune and other diseases.

Organized by:

Cambridge Healthtech Institute

Invited Speakers:

Dr. Carl R. Merril, National Institutes of Health
Dr. Jonathan Blum, Harvard Medical School
Dr. Renata Pasqualini, M.D. Anderson Cancer Center
Dr. Dieter Willbold, Institute for Molecular Biology, Jena Antibody Engineering
Dr. K. Dane Wittrup, Massachusetts Institute of Technology
Dr. James Marks, University of California, San Francisco

Deadline for Abstracts:

March 9, 2001

Registration:

Available on-line

E-mail:

jlaakso@healthtech.com

Posted by:

Jennifer Laakso

Host:

wks217.healthtech.com